Abstract:Introduction Gastric cancer (GC) has a high incidence and mortality rate, especially in East Asians, and about 90% of GCs are adenocarcinomas. Histological and etiological heterogeneity and ethnic diversity make molecular subtyping of GC complicated, thus making it difficult to determine molecular division systems and standard treatment modalities. Limited cohorts from South Korea, Singapore, Australia, and Japan have been studied; however, the mutational landscape of gastric adenocarcinomas in Chinese patients is still unknown.Methods We performed a targeted sequencing panel focusing on cancer-related genes and tumor-associated microorganisms of 529 gastric adenocarcinoma samples with matched blood controls. We identified 449 clinically relevant gene mutations.Results Approximately 47.1% of Chinese patients with GC harbored at least one actionable mutation. The top somatic mutations were TP53, ARID1A, LRP1B, PIK3CA, ERBB2, CDH1, KRAS, FAT4, CCNE1, and KMT2D. Truncation mutations of ARID1A, KMT2D, RNF43, TGFBR2, and CIC occurred in patients with high tumor mutational burden. Gene amplifications of ERBB2, CCNE1, CDK12, and CCND1 were detected in patients with low tumor mutational burden. Pathway analysis revealed common gene alterations in the Wnt and PI3K/Akt signaling pathways. The ratio of patients with high microsatellite instability was significantly lower than other cohorts, and high microsatellite instability and Epstein-Barr virus (EBV)-positive features seemed mutually inclusive in Chinese patients with GC. In 44 (8.3%) patients, 45 germline mutations were identified, among which SPINK1 mutations, all SPINK1 c.194 + 2T > C, were present in 15.9% (7/44) of patients. Microorganisms found in Chinese patients with GC included Helicobacter pylori, EBV, hepatitis B virus, and human papillomavirus types 16 and 18.Conclusion Identification of varied molecular features by targeted next-generation sequencing provides more insight into patient stratification and offers more possibilities for both targeted therapies and immunotherapies of Chinese patients with GC.Implications for Practice This study investigated the genomic alteration profile of 529 Chinese patients with gastric adenocarcinoma by deep targeting sequencing, which might be the largest Chinese cohort on the genomic research of gastric adenocarcinoma up to now.

Comprehensive Genetic Mutation Analysis of Human Gastric Adenocarcinomas.

Genetic Mutation Analysis of Human Gastric Adenocarcinomas Using Ion Torrent Sequencing Platform

A Multi-Gene Model Effectively Predicts the Overall Prognosis of Stomach Adenocarcinomas with Large Genetic Heterogeneity Using Somatic Mutation Features.

Identification Of Genetic Mutations In Human Lung Cancer By Targeted Sequencing

Comprehensive Characterization of the Genomic Alterations in Human Gastric Cancer.

Detection of a Novel Panel of 24 Genes with High Frequencies of Mutation in Gastric Cancer Based on Next-Generation Sequencing.

Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing

Deep Targeted Sequencing And Its Potential Implication For Cancer Therapy In Chinese Patients With Gastric Adenocarcinoma

Whole-genome Reconstruction and Mutational Signatures in Gastric Cancer

Mutational Landscape of Gastric Adenocarcinoma in Chinese: Implications for Prognosis and Therapy.

The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach Adenocarcinoma.

Genomic Alterations in Advanced Gastric Cancer Endoscopic Biopsy Samples Using Targeted Next-Generation Sequencing

Altered 5-Hydroxymethylcytosine Landscape in Primary Gastric Adenocarcinoma

Frequent Mutations in MLH1, MET, KIT, PDGFRA, and PIK3CA Genes in Human Gastrointestinal Stromal Tumors.

Mutational Analysis on Gastric, Duodenal, Bone, and Mediastinal Lymph Node Metastases and Blood from a Case of Primary Lung Adenocarcinoma

Comprehensive genomic profiling and prognostic analysis of cervical gastric-type mucinous adenocarcinoma

Frequent KIT Mutations in Human Gastrointestinal Stromal Tumors.

Mutational analysis of driver genes with tumor suppressive and oncogenic roles in gastric cancer

Transcriptome Sequencing Identifies Prognostic Genes Involved in Gastric Adenocarcinoma.

Integration of DNA Copy Number Alterations and Transcriptional Expression Analysis in Human Gastric Cancer

A Four−Gene-Based Risk Score with High Prognostic Value in Gastric Cancer